球形吸着炭クレメジン®の薬物相互作用
スポンサーリンク
概要
- 論文の詳細を見る
Kremezin® is an oral adsorbent that has been used for improving uremic symptoms and delaying the initiation of dialysis in patients with chronic kidney disease. Kremezin causes various drug interactions by adsorbing molecules of coadministered drugs in the gastrointestinal tract. In human studies, reduction in plasma concentrations of several drugs including aspirin, amlodipine and triazolam has been reported when administered simultaneously with Kremezin. However, a dosing interval of 30 to 90 min between Kremezin and other drugs renders the interaction insignificant. With limited clinical evidence available currently, it is unlikely that the extent of drug interaction with Kremezin can be predicted accurately. Hence, simultaneous administration of Kremezin with other drugs should be avoided, especially for drugs with narrow therapeutic ranges. Careful monitoring of drug effects and markers including drug levels in serum or blood is necessary in case of concurrent use with Kremezin. (Jpn J Clin Pharmacol Ther 2013; 44(2): 77-84)
- 一般社団法人 日本臨床薬理学会の論文
一般社団法人 日本臨床薬理学会 | 論文
- 臨床家の立場より : 脳循環代謝改善薬
- 生体肝移植ならびに小腸移植術後のタクロリムス投与方法
- 甲状腺機能低下によりWarfarin効果の減弱がみられた症例
- 治験の品質管理における治験コーデイネーターの役割
- 治験,臨床試験,臨床研究とCRC